Natural Blood and Blood Product Toxicity

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-10-20
Clinical Trial Update: A Randomized, Double-blinded, Active Controlled Crossover Clinical Trial to Investigate PK, PD and Safety of GBPD002 [Phase 1, Phase 2]
Phase 1/2 randomized crossover trial assessing PK, PD, and safety of GBPD002; study completed.